New inhibitor for treatment of inflammatory diseases

[MSUK]

Scientists have developed a new inhibitor for the treatment of inflammatory diseases. They have come up with a potent, selective, small-molecule inhibitor called MCC950. MCC950 is the inhibitor of NLRP3, a NOD-like receptor (NLR) family, pyrin domain–containing protein 3 inflammasome. NLRP3 inflammasome s a component of the inflammatory process, and its activation is pathogenic in conditions like multiple sclerosis, type 2 diabetes, Alzheimer’s disease and atherosclerosis....... Read More - http://www.ms-uk.org/braininflammation